ONCOMAL ApS (CVR 34580367) Company Profile

Ownership

Thor Grundtvig Theander
10% to under 15% of capital and votesclass Bnotified 27 Mar 2024since 9 May 2012
Ali El-Salanti
20% to under 25% of capital and votesclass Bnotified 27 Mar 2024since 9 May 2012
Mads Daugaard
10% to under 15% of capital and votesclass Bnotified 15 Jun 2018since 9 May 2012
Morten Agertoug Nielsen
5% to under 10% of capital and votesclass Bnotified 21 May 2012since 9 May 2012
Anna Madeleine Dahlbäck
5% to under 10% of capital and votesclass Bnotified 21 May 2012since 9 May 2012
Sitour Management Gesellschaft m.b.H.
5% to under 10% of capital and votesclass Anotified 30 Jun 2025since 28 Oct 2020
JR Investment GmbH
20% to under 25% of capital and votesclass Anotified 30 Jun 2025since 1 Apr 2022

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Former owners (1)

W.E. Industries Ltd.
5% to under 10% of capital and votes24 Aug 2015 to 15 May 2018

Owned Companies

1 Danish company, which own 1 more one level down.

VAR2 PHARMACEUTICALS ApS
SubsidiaryCVR 3462194290% to under 100% of capital and votes
- VarCT Diagnostics ApS
  SubsidiaryCVR 3873356766.7% to under 90% of capital and votes

Found by searching the CVR owner register (ejerregister) for ONCOMAL ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.

People

Current (8)

Thor Grundtvig TheanderExecutive board since 9 May 2012, Board of directors since 14 May 2016
Ali El-SalantiExecutive board since 9 May 2012, Board of directors since 14 May 2016
Mads DaugaardExecutive board since 9 May 2012, Board of directors since 14 May 2016
Peter SchröcksnadelBoard of directors since 14 May 2016
Poul Henrik Bredahl SørensenBoard of directors since 14 May 2016
Josef RainerBoard of directors since 1 Apr 2022
Tanja RainerBoard of directors since 30 Jun 2025
Silviya StoykovaBoard of directors since 30 Jun 2025

Founders (3)

Ali El-SalantiFounded 9 May 2012, holds a current role
Mads DaugaardFounded 9 May 2012, holds a current role
Thor Grundtvig TheanderFounded 9 May 2012, holds a current role

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Former (1)

Mai-Britt ZoccaBoard of directors 14 May 2016 to 18 May 2019

Network

Roles Over Time

Thor Grundtvig Theander: Executive board, 9 May 2012 to today; Board of directors, 14 May 2016 to today.
Ali El-Salanti: Executive board, 9 May 2012 to today; Board of directors, 14 May 2016 to today.
Mads Daugaard: Executive board, 9 May 2012 to today; Board of directors, 14 May 2016 to today.
Peter Schröcksnadel: Board of directors, 14 May 2016 to today.
Poul Henrik Bredahl Sørensen: Board of directors, 14 May 2016 to today.
Josef Rainer: Board of directors, 1 Apr 2022 to today.
Tanja Rainer: Board of directors, 30 Jun 2025 to today.
Silviya Stoykova: Board of directors, 30 Jun 2025 to today.

9 May 2012 to 8 Nov 2026.

Former (1)

Mai-Britt Zocca: Board of directors, 14 May 2016 to 18 May 2019.

14 May 2016 to 8 Nov 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Network

Headcount

CVR holds no employment figures for this company.

Financials

Annual report figures by year, DKK thousands
Metric	2021	2022	2023	2024	2025
Gross profit	-321	-230	-54	-171	-516
Operating profit	-321	-230	-54	-171	-516
Result for the year	-628	-639	-725	-1,216	-1,882
Equity	65,142	101,700	100,974	137,043	232,154
Total assets	75,894	115,686	121,221	164,053	266,118
Employees (average)	Not reported	Not reported	Not reported	Not reported	0
Credit metrics (Dandex calculations)
Net interest-bearing debt (NIBD, nettorentebærende gæld)	-6,749^{note 1}	-8,512^{note 1}	-11,435^{note 1}	-17,071^{note 1}	-22,133^{note 1}
ROIC (afkast af investeret kapital)	-0.4%^{note 2}	-0.2%^{note 2}	-0.1%^{note 2}	-0.1%^{note 2}	-0.2%^{note 2}
Capex (investeringer i anlægsaktiver)	Not reported^{note 3}	Not reported^{note 3}	Not reported^{note 3}	Not reported^{note 3}	0^{note 4}
NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender)	3,945^{note 1}	5,441^{note 1}	8,789^{note 1}	9,914^{note 1}	11,797^{note 1}

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).

1 no interest-bearing debt reported
2 Dandex estimate: statutory 22% used: profit before tax not positive; no interest-bearing debt reported
3 no capex filed
4 tangible assets only

Annual Reports

Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 8 Jun 2026
XHTML
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 27 May 2025
PDF
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 27 May 2024
PDF
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 2 Jun 2023
PDF
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 8 Apr 2022
PDF

Financials

Changes

All changes

6 May 2026
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 6. maj 2026: 1 indtrådt.
6 May 2026
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 6. maj 2026: 1 indtrådt.
30 Jun 2025
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 30. juni 2025: 2 indtrådt.
30 Jun 2025
Director change
ONCOMAL ApS (CVR 34580367) har foretaget direktørskifte pr. 30. juni 2025: 2 indtrådt.
30 Jun 2025
Director change
ONCOMAL ApS (CVR 34580367) har foretaget direktørskifte pr. 30. juni 2025: 2 indtrådt.
30 Jun 2025
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 30. juni 2025: 2 indtrådt.
27 Mar 2024
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 27. marts 2024: 2 indtrådt.
27 Mar 2024
Ownership change
ONCOMAL ApS (CVR 34580367) har foretaget ejerskifte pr. 27. marts 2024: 2 indtrådt.
1 Apr 2022
Director change
ONCOMAL ApS (CVR 34580367) har foretaget direktørskifte pr. 1. april 2022: 1 indtrådt.
1 Apr 2022
Director change
ONCOMAL ApS (CVR 34580367) har foretaget direktørskifte pr. 1. april 2022: 1 indtrådt.

Changes

Registry Facts

Signing rule (Tegningsregel): Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.since 27 May 2016
Purpose (Formål): Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber at drive virksomhed indenfor kræftbekæmpelse samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.since 21 Apr 2022
Audit opted out (Revision fravalgt): Nosince 9 May 2012
Articles of association last changed (Seneste vedtægtsdato): 30 Jun 2025
Share classes (Kapitalklasser): Yessince 5 Aug 2026
Owners under 5% registered (Ejerregistrering under 5 procent): Nosince 26 May 2016

Share Capital

Each registered value from the day it took effect, newest first.

30 Jun 2025132,875 DKK+22,972
27 Mar 2024109,903 DKK+6,939
1 Apr 2022102,964 DKK+6,116
15 Jun 201896,848 DKK+4,858
15 May 201891,990 DKK+1,034
15 May 201790,956 DKK+1,034

Earlier values (4)

14 May 201689,922 DKK+1,034
24 Aug 201588,888 DKK+4,894
1 Nov 201383,994 DKK+3,994
9 May 201280,000 DKKEarliest in CVR

From CVR, read 8 Nov 2026. Text such as the signing rule and purpose is shown as registered.

Registry Facts

Registrations (Registreringer)

22 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.

5 Aug 2026
Capital change
Kapital: kr. 132.875,00, delvist indbetalt. Tidligere kapital er nu fuldt indbetalt.
10 Apr 2026
People change
Bestyrelse:
Tiltrådte:
Silviya Stoykova, den 30.06.2025.
7 Apr 2026
People change
Bestyrelse:
Tiltrådte:
Tanja Rainer, den 30.06.2025.
17 Jul 2025
Capital change
Vedtægter ændret: 30.06.2025
Kapitalforhøjelsen er besluttet den 30.06.2025.
kr. 16.913,00, indbetalt kontant, kurs 485.247,00, heraf samlet indbetalt kr. 6.150,00. kr. 4.475,00, indbetalt kontant, kurs 333.450,00, heraf samlet indbetalt kr. 2.237,00. kr. 469,00, indbetalt kontant, kurs 100,00, heraf samlet indbetalt kr. 469,00. kr. 1.115,00, indbetalt kontant, kurs 100,00, heraf samlet indbetalt kr. 1.115,00.
Kapitalen udgør herefter kr. 132.875,00, delvist indbetalt.
Kapitalen er opdelt i klasser.
3 Apr 2024
Capital change
Vedtægter ændret: 27.03.2024
Kapitalforhøjelsen er besluttet den 27.03.2024.
kr. 5.842,00, indbetalt kontant, kurs 638.206,09. kr. 1.097,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 109.903,00.
14 Mar 2024
Address change
Ny adresse: c/o Symbion Fuglebakken, Nordre Fasanvej 215, 2000 Frederiksberg
Ny kommune: Frederiksberg
2 May 2022
Capital change People change
Vedtægter ændret: 01.04.2022
Kapitalforhøjelsen er besluttet den 01.04.2022.
kr. 5.149,00, indbetalt kontant, kurs 722.382,99. kr. 967,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 102.964,00.
Bestyrelse:
Tiltrådte:
Josef Rainer, den 01.04.2022.
Formål ændret: Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber at drive virksomhed indenfor kræftbekæmpelse samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
3 Jun 2019
People change
Bestyrelse:
Fratrådte:
Mai-Britt Zocca, den 18.05.2019.
28 Jun 2018
Capital change
Vedtægter ændret: 15.06.2018
Kapitalforhøjelsen er besluttet den 15.06.2018.
kr. 4.858,00, indbetalt kontant, kurs 766.831,00.
Kapitalen udgør herefter kr. 96.848,00.
29 May 2018
Capital change
Vedtægter ændret: 15.05.2018
Kapitalforhøjelsen er besluttet den 15.05.2018.
kr. 94,00, indbetalt kontant, kurs 792.468,00.
Kapitalen udgør herefter kr. 91.990,00.

Show 12 more

29 May 2018
Capital change
Vedtægter ændret: 15.05.2018
Kapitalforhøjelsen er besluttet den 15.05.2018.
kr. 940,00, indbetalt kontant, kurs 792.468,00.
Kapitalen udgør herefter kr. 91.896,00.
1 Jun 2017
Other
Vedtægter ændret: 20.05.2017
17 May 2017
Capital change
Kapitalforhøjelsen er besluttet den 15.05.2017.
kr. 94,00, indbetalt kontant, kurs 791.500,00.
Kapitalen udgør herefter kr. 90.956,00.
15 May 2017
Capital change
Vedtægter ændret: 15.05.2017
Kapitalforhøjelsen er besluttet den 15.05.2017.
kr. 940,00, indbetalt kontant, kurs 791.500,00.
Kapitalen udgør herefter kr. 90.862,00.
6 Jun 2016
People change
Bestyrelse:
Tiltrådte:
Poul Henrik Bredahl Sørensen, den 14.05.2016.
27 May 2016
Capital change
Kapitalforhøjelsen er besluttet den 14.05.2016.
kr. 94,00, indbetalt kontant, kurs 791.468,00.
Kapitalen udgør herefter kr. 89.922,00.
27 May 2016
Capital change
Kapitalforhøjelsen er besluttet den 14.05.2016.
kr. 940,00, indbetalt kontant, kurs 791.468,00.
Kapitalen udgør herefter kr. 89.828,00.
27 May 2016
People change
Vedtægter ændret: 14.05.2016
Bestyrelse:
Tiltrådte:
Mads Daugaard (formand), den 14.05.2016, Ali El-Salanti, den 14.05.2016, Thor Grundtvig Theander, den 14.05.2016, Peter Schröcksnadel, den 14.05.2016, Mai-Britt Zocca, den 14.05.2016.
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse..
24 Aug 2015
Capital change
CVR-nummer:
34580367.
NAVN:
ONCOMAL ApS.
Adresse: c/o COBIS, Ole Maaløes Vej 3, 2200 København N.
Kommune: København.
Show the full announcement
Vedtægter ændret: 24.08.2015
Kapitalforhøjelse: kr. 4.894,00, indbetalt kontant, kurs 69.406,54.
Kapitalen udgør herefter kr. 88.888,00.
11 Aug 2015
Address change
CVR-nummer:
34580367.
NAVN:
ONCOMAL ApS.
Adresse: Smørumvej 50, 2700 Brønshøj.
Kommune: København.
Ny adresse: c/o COBIS, Ole Maaløes Vej 3, 2200 København N
Ny kommune: København
9 Jul 2014
Capital change Other
Vedtægter ændret:
01.11.2013.
Kapitalforhøjelse kr. 3.994,00: kr. 1.546,00 indbetalt kontant, kurs 100,00. kr. 2.448,00 indbetalt kontant, kurs 73.549,44.
Kapitalen udgør herefter kr. 83.994,00.
23 May 2012
New company
Stiftelsesdato:
09.05.2012.
Seneste vedtægtsdato:
09.05.2012.
Kapital:
kr. 80.000,00.
Show the full announcement
Indbetalingsmåde:
Indbetalt i værdier kr. 80.000,00 til kurs 100,00.
Stiftere:
Mads Daugaard, den 09.05.2012, Ali El-Salanti, den 09.05.2012, Thor Grundtvig Theander, den 09.05.2012.
Direktion:
Mads Daugaard, den 09.05.2012, Ali El-Salanti, den 09.05.2012, Thor Grundtvig Theander, den 09.05.2012.
Selskabet tegnes af en direktør.
Revision:
CVR-NR. 14119299 PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, 2600 Glostrup, den 09.05.2012.
Første regnskabsår:
09.05.2012 - 31.12.2012.
Regnskabsår:
01.01 - 31.12.

Registrations (Registreringer)

Registration

Address: Nordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality
CVR record last changed: 28 Oct 2026
Data read: 8 Nov 2026

Production Units

1 registered in CVR.

ONCOMAL ApS
P-number 1017687715Nordre Fasanvej 215, 2000 Frederiksberg

Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ownership

People

Network

Headcount

Financials

Changes

Registry Facts

Registrations (Registreringer)

Registration

Dandex in Your Own Tools

Ownership

People

Financials

Who Is Behind It

Ownership

Owned Companies

People

Current (8)

Founders (3)

Network

Roles Over Time

Network

Headcount

Financials

Annual Reports

Financials

Changes

Changes

Registry Facts

Share Capital

Registry Facts

Registrations (Registreringer)

Registrations (Registreringer)

Registration

Production Units

Dandex in Your Own Tools

Who Is Behind It

Owned Companies

Current (8)

Founders (3)

Network

Shared by two or more of its people

Owners and the control chain

Companies it owns

Its people and their other companies

Network

Roles Over Time

Financials

Annual Reports

Changes

Registry Facts

Share Capital

Registrations (Registreringer)

Production Units

Network

Shared by two or more of its people

Owners and the control chain

Companies it owns

Its people and their other companies